核磁共振成像在宫颈癌分期诊断中的价值研究

Value of magnetic resonance imaging in staging of cervical cancer

目的探讨核磁共振成像(MRI)对宫颈癌分期诊断的价值。方法选取2019年8月至2021年5月在本院治疗的17例宫颈癌患者为研究对象,均行MRI检查,以手术病理诊断结果为依据,记录MRI诊断宫颈癌分期的结果,并观察MRI诊断与手术病理诊断的分期结果的符合率。结果17例患者中,手术病理诊断的分期为IB1期5例,IB2期3例,IB3期2例,IIA1期3例,ⅡA2期2例,ⅢC1期2例。MRI诊断的以上分期患者分别为5例、3例、2例、2例、1例、2例,MRI诊断符合率为88.24%。MRI诊断与手术病理诊断的分期结果比较,差异无统计学意义(P>0.05)。结论MRI诊断的宫颈癌分期与病理分期符合度较高,尤其是IB1、IIA2期患者,可为临床诊疗提供重要参考依据。

Objective To explore the value of magnetic resonance imaging(MRI)in staging of cervical cancer.Methods A total of 17 cervical cancer patients treated in our hospital from August 2019 to May 2021 were selected as study objects,and all patients underwent MRI examination.Based on the results of surgical pathological diagnosis,the results of MRI in diagnosis of cervical cancer staging were recorded and the coincidence rate of MRI diagnosis and surgical pathological diagnosis was observed.Results Of 17 patients,5 patients were in IB1 stage,3 in IB2 stage,2 in IB3 stage,3 in A1 stage,2 in A2 stage and 2 inⅢC1stage.The number of patients with the same staging above diagnosed by MRI was 5,3,2,2,1and 2,with a diagnostic concordance rate of 88.24%.There was no significant difference in staging compared with surgical pathological diagnosis results(P>0.05).Conclusion MRI complies with staging of cervical cancer by surgical pathological diagnosis,especially in patients with stages of IB1 and IIA2,which can provide an important reference for clinical diagnosis and treatment.